Veradigm (NASDAQ:MDRX) Shares Down 12.5% – Here’s What Happened

Veradigm Inc. (NASDAQ:MDRX)’s stock price dropped 12.5% during trading on Monday . The company traded as low as $4.53 and last traded at $4.53. Approximately 100 shares traded hands during trading, a decline of 100% from the average daily volume of 165,931 shares. The stock had previously closed at $5.18.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Stock Down 7.3%

The stock has a market cap of $577.92 million, a price-to-earnings ratio of 23.25 and a beta of 0.55. The company’s fifty day moving average is $4.67 and its two-hundred day moving average is $4.66.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.